Skip to main content
Clinical Trials/NCT06404632
NCT06404632
Recruiting
Not Applicable

A Group Intervention for Promoting Health-related Habits in Individuals With Disabilities (LEV-G)

Region Stockholm1 site in 1 country30 target enrollmentApril 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Life Style
Sponsor
Region Stockholm
Enrollment
30
Locations
1
Primary Endpoint
Completion rate participants
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Health-related habits influences mental and physical health. Still, treatment of health-related habits, which can help to remedy health problems, is often not done at all or very superficially. Multiple guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings. The Lev-g intervention is intended for groups. There is also an individual version of Lev that has its on registration in Clinical Trails.

Detailed Description

Lev is a brief, transdiagnostic, interprofessional intervention targeting health-related habits that is intended for several care settings. The main population intended is individuals with neurodevelopmental disorders or parents or close relations to children with disabilities. This study will therefore be open for participants recruited from several types of healthcare services in Sweden. Study 1: The feasibility trial investigates the following questions: Completion: How many participants that started Lev completed the intervention? What were the reasons for not not completing Lev? How many sessions did the participants complete? Lev includes screening (Lev-s), three sessions + one booster session. Level of acceptability: Was Lev perceived as creditable and satisfactory by healthcare workers and participants? Treatment credibility will be measured before Lev and after the last session for both participants and healthcare workers. Treatment satisfaction will be evaluated after each session and after the intervention is completed. Session evaluations will be done by both participants and healthcare workers. Do the intervention lead to adverse events? To what extent were individual goals met?

Registry
clinicaltrials.gov
Start Date
April 12, 2024
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Douglas Sjowall

PhD, Associate professor

Region Stockholm

Eligibility Criteria

Inclusion Criteria

  • both adults with and without disabilities recruited from different healthcare contexts.

Exclusion Criteria

  • Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
  • Insufficient command of the Swedish language/ unable to understand the content.
  • Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).

Outcomes

Primary Outcomes

Completion rate participants

Time Frame: within 3-4 months

How many of the participants that started using Lev (i.e., completing screening with Lev-s) completed Lev (i.e., completing, 3 out of 4 session)

Secondary Outcomes

  • Level of treatment credibility healthcare workers(Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months)I.e within 6 weeks)
  • Treatment satisfaction participants (the three sessions)(Directly after completing the last treatment module in LEV (approximately at 3-4 weeks from baseline)])
  • Treatment satisfaction healthcare workers (individual sessions)(After completing the first session in Lev. An average of 3-4 months from baseline)
  • To what extent were individual goals met?(Directly after completing the booster session module in LEV (approximately at 3-4 months))
  • Treatment satisfaction participants (individual sessions)(After completing the booster session in Lev. An average of 3-4 month from baseline)
  • Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire for participants(Directly after completing the booster session in LEV (approximately at 3-4 month from baseline)])
  • Well-being before and after the intervention measures by The Evaluation Questionnaire(Directly after completing the booster session module in LEV (approximately at 3-4 months))
  • Do Lev lead to healthier habits?(Before and after taking part in Lev (after is after the third, 3-4 weeks, as wells as after the booster session, 3-4 month))
  • Level of treatment credibility participants(Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months). I.e within 6 weeks)
  • Treatment satisfaction participants (the whole intervention including the booster session)(Directly after completing the last treatment module in LEV (approximately at 3-4 month from baseline)])
  • Adverse events after the intervention(During the intervention up to week approximately 3-4 months)
  • Self-efficacy for promoting health behaviors for their children(Directly after completing the booster session in LEV (approximately at 3-4 month))

Study Sites (1)

Loading locations...

Similar Trials